Antimicrobial treatment of Capnocytophaga infections

Brenner, 1989, Capnocytophaga canimorsus sp. nov. (formerly CDC group DF-2), a cause of septicemia following dog bite, and C. cynodegmi sp. nov., a cause of localized wound infection following dog bite, J Clin Microbiol, 27, 231, 10.1128/JCM.27.2.231-235.1989

Yamamoto, 1994, Capnocytophaga haemolytica sp. nov. and Capnocytophaga granulosa sp. nov., from human dental plaque, Int J Syst Bacteriol, 44, 324, 10.1099/00207713-44-2-324

Laughon, 1982, API ZYM system for identification of Bacteroides spp., Capnocytophaga spp., and spirochetes of oral origin, J Clin Microbiol, 15, 97, 10.1128/JCM.15.1.97-102.1982

Ciantar, 2005, Molecular identification of Capnocytophaga spp. via 16S rRNA PCR-restriction fragment length polymorphism analysis, J Clin Microbiol, 43, 1894, 10.1128/JCM.43.4.1894-1901.2005

Gerster, 2004, Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis, Clin Rheumatol, 23, 570, 10.1007/s10067-004-0950-3

Gottwein, 2006, Etiologic diagnosis of Capnocytophaga canimorsus meningitis by broad-range PCR, Eur J Clin Microbiol Infect Dis, 25, 132, 10.1007/s10096-006-0095-1

Alugupalli, 1996, Degradation of lactoferrin by periodontitis-associated bacteria, FEMS Microbiol Lett, 145, 209, 10.1111/j.1574-6968.1996.tb08579.x

Kim, 1994, B-cell mitogenicity and IL-1 beta production of lipopolysaccharides from various Capnocytophaga strains, Bull Tokyo Dent Coll, 35, 79

Wilson, 1987, Capnocytophaga species: increased resistance of clinical isolates to serum bactericidal action, J Infect Dis, 156, 99, 10.1093/infdis/156.1.99

Shurin, 1979, A neutrophil disorder induced by Capnocytophaga, a dental micro-organism, N Engl J Med, 301, 849, 10.1056/NEJM197910183011601

Parenti, 1985, Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts, J Infect Dis, 151, 140, 10.1093/infdis/151.1.140

Goudreau, 1986, Capnocytophaga ochracea and group F beta-hemolytic Streptococcus suppurative thyroiditis, J Otolaryngol, 15, 59

Campbell, 1991, Capnocytophaga species infections in children, Pediatr Infect Dis J, 10, 944, 10.1097/00006454-199112000-00013

Sixou, 2006, Capnocytophaga in the dental plaque of immunocompromised children with cancer, Int J Paediatr Dent, 16, 75, 10.1111/j.1365-263X.2006.00697.x

Sixou, 1996, Modifications of the microflora of the oral cavity arising during immunosuppressive chemotherapy, Eur J Cancer B Oral Oncol, 32B, 306, 10.1016/0964-1955(96)00006-1

Alexandrakis, 2000, Capnocytophaga keratitis, Ophthalmology, 107, 1503, 10.1016/S0161-6420(00)00227-X

Chodosh, 2001, Cat's tooth keratitis: human corneal infection with Capnocytophaga canimorsus, Cornea, 20, 661, 10.1097/00003226-200108000-00021

Font, 1994, Capnocytophaga keratitis. A clinicopathologic study of three patients, including electron microscopic observations, Ophthalmology, 101, 1929, 10.1016/S0161-6420(94)31081-5

Phipps, 2002, Capnocytophaga canimorsus endophthalmitis following cataract surgery, Clin Experiment Ophthalmol, 30, 375, 10.1046/j.1442-9071.2002.00561.x

Bonatti, 2003, A series of infections due to Capnocytophaga spp in immunosuppressed and immunocompetent patients, Clin Microbiol Infect, 9, 380, 10.1046/j.1469-0691.2003.00538.x

Mosher, 1986, Mediastinal abscess with Capnocytophaga spp. in a competent host, J Clin Microbiol, 24, 161, 10.1128/JCM.24.1.161-162.1986

Sabbatani, 2004, Capnocytophaga spp. brain abscess in an immunocompetent host: problems in antimicrobial chemotherapy and literature review, J Chemother, 16, 497, 10.1179/joc.2004.16.5.497

Seger, 1982, Cervical abscess due to Capnocytophaga ochracea, Pediatr Infect Dis, 1, 170, 10.1097/00006454-198205000-00009

Handal, 2005, Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp, Antimicrob Agents Chemother, 49, 3940, 10.1128/AAC.49.9.3940-3943.2005

Mortensen, 1985, Peritonitis involving Capnocytophaga ochracea, Diagn Microbiol Infect Dis, 3, 359, 10.1016/0732-8893(85)90011-2

Bernard, 1981, Septicémie à Capnocytophaga ochracea Un risque de l’agranulocytose, Nouv Presse Med, 10, 3651

Bilgrami, 1992, Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: a case report and review, Clin Infect Dis, 14, 1045, 10.1093/clinids/14.5.1045

Gandola, 1980, Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis, Arch Intern Med, 140, 851, 10.1001/archinte.140.6.851

Gomez-Garces, 1994, Bacteremia by multidrug-resistant Capnocytophaga sputigena, J Clin Microbiol, 32, 1067, 10.1128/JCM.32.4.1067-1069.1994

Lin, 1998, Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates, J Formos Med Assoc, 97, 44

Buu-Hoi, 1988, Endocarditis caused by Capnocytophaga ochracea, J Clin Microbiol, 26, 1061, 10.1128/JCM.26.5.1061-1062.1988

Coignard, 1982, Endocarditis caused by Capnocytophaga ochracea, Nouv Presse Med, 11, 1338

Sandoe, 2004, Capnocytophaga canimorsus endocarditis, J Med Microbiol, 53, 245, 10.1099/jmm.0.05274-0

Hager, 1988, Peripartum infections with Capnocytophaga. A case report, J Reprod Med, 33, 657

Tay, 1985, Capnocytophaga ochracea pyonephrosis in an infant with obstructive nephropathy, Pediatr Infect Dis, 4, 555, 10.1097/00006454-198509000-00025

Glupczynski, 1983, Ostéite à Capnocytophaga ochracea, Med Mal Infect, 13, 94, 10.1016/S0399-077X(83)80009-2

Winn, 1984, Septic arthritis involving Capnocytophaga ochracea, J Clin Microbiol, 19, 538, 10.1128/JCM.19.4.538-540.1984

Le Moal, 2003, Meningitis due to Capnocytophaga canimorsus after receipt of a dog bite: case report and review of the literature, Clin Infect Dis, 36e, 42, 10.1086/345477

Drouet, 2006, Meningitis due to Capnocytophaga canimorsus without dog bite, Presse Med, 35, 418, 10.1016/S0755-4982(06)74606-1

Rosenman, 2003, Capnocytophaga canimorsus meningitis in a newborn: an avoidable infection, Pediatr Infect Dis J, 22, 204, 10.1097/01.inf.0000048949.21724.78

Bryson, 2003, Purpura fulminans associated with Capnocytophaga canimorsus infection, Br J Haematol, 121, 1, 10.1046/j.1365-2141.2003.04179.x

Addy, 1995, An approach to efficacy screening of mouthrinses: studies on a group of French products (I). Staining and antimicrobial properties in vitro, J Clin Periodontol, 22, 718, 10.1111/j.1600-051X.1995.tb00832.x

Luc, 1998, Activité bactéricide de bains de bouche contenant 0, 10%, 0, 12% et 0, 20% de digluconate de chlorhexidine, J Parodontol Implantol Orale, 17, 441

Wade, 1989, In vitro activity of a chlorhexidine-containing mouthwash against subgingival bacteria, J Periodontol, 60, 521, 10.1902/jop.1989.60.9.521

Okada, 2001, Clinical periodontal findings and microflora profiles in children with chronic neutropenia under supervised oral hygiene, J Periodontol, 72, 945, 10.1902/jop.2001.72.7.945

Bremmelgaard, 1989, Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria, APMIS, 97, 43, 10.1111/j.1699-0463.1989.tb00753.x

Forlenza, 1981, Antimicrobial susceptibility of Capnocytophaga, Antimicrob Agents Chemother, 19, 144, 10.1128/AAC.19.1.144

Foweraker, 1990, Novel beta-lactamase from Capnocytophaga sp, Antimicrob Agents Chemother, 34, 1501, 10.1128/AAC.34.8.1501

Geisler, 2001, Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation, Bone Marrow Transplant, 28, 1171, 10.1038/sj.bmt.1703288

Kinder, 1986, Penicillin resistance in the subgingival microbiota associated with adult periodontitis, J Clin Microbiol, 23, 1127, 10.1128/JCM.23.6.1127-1133.1986

Kolokotronis, 1995, Susceptibility of Capnocytophaga to antimicrobial agents, J Chemother, 7, 414, 10.1179/joc.1995.7.5.414

Nachnani, 1992, E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms, J Periodontol, 63, 576, 10.1902/jop.1992.63.7.576

Roscoe, 1992, Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species, Antimicrob Agents Chemother, 36, 2197, 10.1128/AAC.36.10.2197

Rummens, 1986, In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents, Antimicrob Agents Chemother, 30, 739, 10.1128/AAC.30.5.739

Sutter, 1981, In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents, Antimicrob Agents Chemother, 20, 270, 10.1128/AAC.20.2.270

Baquero, 1990, Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source, Rev Infect Dis, 12, S157, 10.1093/clinids/12.Supplement_2.S157

Mouton, 1984, Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination, J Biol Buccale, 12, 17

Arlet, 1987, In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones, Antimicrob Agents Chemother, 31, 1283, 10.1128/AAC.31.8.1283

Hawkey, 1987, In vitro susceptibility of Capnocytophaga species to antimicrobial agents, Antimicrob Agents Chemother, 31, 331, 10.1128/AAC.31.2.331

Jolivet-Gougeon, 2000, In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors, Antimicrob Agents Chemother, 44, 3186, 10.1128/AAC.44.11.3186-3188.2000

Rosenau, 2000, Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides, Antimicrob Agents Chemother, 44, 760, 10.1128/AAC.44.3.760-762.2000

Sixou, 2003, Microbiology of mandibular third molar pericoronitis: incidence of beta-lactamase-producing bacteria, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 95, 655, 10.1067/moe.2003.238

Stefanopoulos, 2005, Facial bite wounds: management update, Int J Oral Maxillofac Surg, 34, 464, 10.1016/j.ijom.2005.04.001

Roscoe, 1993, Resistance of Capnocytophaga species to beta-lactam antibiotics, Clin Infect Dis, 17, 284, 10.1093/clinids/17.2.284

Roscoe, 1993, Antimicrobial susceptibility of Capnocytophaga spp (author's reply), Antimicrob Agents Chemother, 37, 1206, 10.1128/AAC.37.5.1206

Verghese, 1993, Antimicrobial susceptibility of Capnocytophaga spp, Antimicrob Agents Chemother, 37, 1206, 10.1128/AAC.37.5.1206

Rubie, 1988, Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin, Pathol Biol, 36, 912

Cormican, 1995, Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens), Diagn Microbiol Infect Dis, 22, 43, 10.1016/0732-8893(95)00042-9

Kawakami, 1998, Evaluation of a new method for susceptibility testing against fastidious and unusual bacteria, Kansenshogaku Zasshi, 72, 1017, 10.11150/kansenshogakuzasshi1970.72.1017

Jolivet-Gougeon, 2004, Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea, J Clin Microbiol, 42, 888, 10.1128/JCM.42.2.888-890.2004

Jolivet-Gougeon, 2005, Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period, BMC Infect Dis, 5, 32, 10.1186/1471-2334-5-32

Maury, 1999, Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of β-lactamase-producing strains, Clin Infect Dis, 28, 1172, 10.1086/517772

Lion, 1996, Capnocytophaga canimorsus infections in human: review of the literature and cases report, Eur J Epidemiol, 12, 521, 10.1007/BF00144007